John Meadows joins One Medical Passport as SVP of sales

One Medical Passport brought John Meadows on board as senior vice president of sales.

Advertisement

Mr. Meadows has more than 30 years of experience in building and leading sales organizations in medical software, medical devices and consumer products. Throughout his career, he worked with companies such as Boston Scientific, PepsiCo and SC Johnson.

In his new role, Mr. Meadows is responsible for growing the company’s ASC, hospital and physician practice market reach as well as overseeing the company’s expansion into new markets and partnerships. He will also play a role in PassportEngage’s rollout.

PassportEngage is an engagement solution scheduled for an early 2016 release.

“Healthcare is changing quickly, it is becoming much more ‘patient-centric’ and One Medical Passport has been on the cutting-edge of that change,” said Mr. Meadows. “The term ‘patient-engagement’ was not well known 16 years ago when Steve Punzak founded the company, but he has a vision of the future and he was right.”

More articles on surgery centers:
6 ASC technologies to know
Regent Surgical Health partners with Alaska ASC: 5 key notes
The best decision 9 ASC administrators made this year

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.